Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation: Implications for Drug Therapy of Neonates

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.42, Iss.5, 2003-01, pp. : 403-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Midazolam and Its Metabolites during Venoarterial Extracorporeal Membrane Oxygenation in Neonates

By Ahsman Maurice J.

Clinical Pharmacokinetics, Vol. 49, Iss. 6, 2010-06 ,pp. : 407-419

Adis International

Access to resources Recommend Favorite

Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy

By Di Paolo N. Gaggiotti E. Galli F.

Redox Report, Vol. 10, Iss. 3, 2005-06 ,pp. : 121-130

Maney Publishing

Access to resources Recommend Favorite

Morphine Metabolite Pharmacokinetics during Venoarterial Extra Corporeal Membrane Oxygenation in Neonates

By Peters Jeroen W.B. Anderson Brian J.

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 705-714

Adis International

Access to resources Recommend Favorite

Extracorporeal membrane oxygenation in the treatment of poisoned patients

By de Lange D. W. Sikma M. A. Meulenbelt J.

Clinical Toxicology, Vol. 51, Iss. 5, 2013-06 ,pp. : 385-393

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)

Current Drug Metabolism, Vol. 13, Iss. 6, 2012-07 ,pp. : 767-777

Bentham Science Publishers

Access to resources Recommend Favorite